Table-II.

Comparison of exacerbation from baseline to 6th month with study groups.

			Study Groups		Total	p-value
			A	B
Exacerbation	Baseline	Present	60	60	120	0.999
		Absent	0	0	0
	2nd month	Present	39	40	79	0.847
		Absent	21	20	41
	4th month	Present	24	23	47	0.852
		Absent	36	37	73
	6th month	Present	0	4	4	0.042
		Absent	60	56	116